A proven approach to clinical trial site identification.

This week's Fierce Biotech is brought to you by Altasciences.

Trouble viewing? Click here.

Altasciences
 

Watch the first episode in our new multi-site clinical trial podcast series to discover Altasciences' unique process for identifying and selecting the right clinical sites for your project. Our approach ensures a solid plan with a quick turnaround at the feasibility stage.

Key elements include:
  • early engagement with sites;
  • comprehensive feasibility assessments; and
  • flexible hybrid solutions leveraging our own clinical facilities.
WATCH NOW
 

Questions about your drug development program? Speak with one of our experts.
  Altasciences has received a 2024 CRO Leadership Award in the Capabilities category, as voted by you in ISR's annual CRO Quality Benchmarking survey.  

Our Solutions

Preclinical Clinical Manufacturing
and Analytical		 Bioanalytical CRO Services

Let's Stay Connected!

LinkedIn LinkedIn    YouTube YouTube    Blog Blog
 
 
Copyright © 2024, Altasciences Company Inc. All rights reserved.

Our mailing address is:
Altasciences
575 Armand-Frappier
Laval, QC, Canada
H7V 4B3

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.


You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017